225 related articles for article (PubMed ID: 22445882)
21. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
[TBL] [Abstract][Full Text] [Related]
22. Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity.
Tanda G; Newman AH; Ebbs AL; Tronci V; Green JL; Tallarida RJ; Katz JL
J Pharmacol Exp Ther; 2009 Sep; 330(3):802-9. PubMed ID: 19483071
[TBL] [Abstract][Full Text] [Related]
23. The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens.
Velázquez-Sánchez C; García-Verdugo JM; Murga J; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():73-80. PubMed ID: 23385166
[TBL] [Abstract][Full Text] [Related]
24. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.
Rothman RB; Baumann MH; Prisinzano TE; Newman AH
Biochem Pharmacol; 2008 Jan; 75(1):2-16. PubMed ID: 17897630
[TBL] [Abstract][Full Text] [Related]
25. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
Acri JB; Siedleck BK; Witkin JM
J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
[TBL] [Abstract][Full Text] [Related]
26. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
27. Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core.
Jocham G; Lezoch K; Müller CP; Kart-Teke E; Huston JP; de Souza Silva MA
Eur J Neurosci; 2006 Sep; 24(6):1721-32. PubMed ID: 17004936
[TBL] [Abstract][Full Text] [Related]
28. Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral sensitization to cocaine.
Beurrier C; Malenka RC
J Neurosci; 2002 Jul; 22(14):5817-22. PubMed ID: 12122043
[TBL] [Abstract][Full Text] [Related]
29. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
[TBL] [Abstract][Full Text] [Related]
30. The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.
Brabant C; Quertemont E; Anaclet C; Lin JS; Ohtsu H; Tirelli E
Psychopharmacology (Berl); 2007 Feb; 190(2):251-63. PubMed ID: 17072589
[TBL] [Abstract][Full Text] [Related]
31. Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.
Simmons D; Self DW
Neuropsychopharmacology; 2009 Jul; 34(8):1946-57. PubMed ID: 19279569
[TBL] [Abstract][Full Text] [Related]
32. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
[TBL] [Abstract][Full Text] [Related]
33. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
Zhang HY; Bi GH; Yang HJ; He Y; Xue G; Cao J; Tanda G; Gardner EL; Newman AH; Xi ZX
Neuropsychopharmacology; 2017 Aug; 42(9):1871-1883. PubMed ID: 28266501
[TBL] [Abstract][Full Text] [Related]
34. Subjective perception of cocaine reward in mice assessed by a single exposure place preference (sePP) paradigm.
Runegaard AH; Jensen KL; Dencker D; Wörtwein G; Gether U
J Neurosci Methods; 2017 Sep; 289():85-92. PubMed ID: 28711378
[TBL] [Abstract][Full Text] [Related]
35. Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.
Panos JJ; Baker LE
Pharmacol Biochem Behav; 2012 Jan; 100(3):377-81. PubMed ID: 21978942
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats.
Izawa J; Yamanashi K; Asakura T; Misu Y; Goshima Y
Eur J Pharmacol; 2006 Nov; 549(1-3):84-90. PubMed ID: 16979160
[TBL] [Abstract][Full Text] [Related]
37. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine.
Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380
[TBL] [Abstract][Full Text] [Related]
38. The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice.
Riday TT; Kosofsky BE; Malanga CJ
Neuropharmacology; 2012 Mar; 62(4):1858-66. PubMed ID: 22197517
[TBL] [Abstract][Full Text] [Related]
39. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
[TBL] [Abstract][Full Text] [Related]
40. Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter.
Wu H; O'Neill B; Han DD; Thirtamara-Rajamani K; Wang Y; Gu HH
Neuropharmacology; 2014 Nov; 86():31-7. PubMed ID: 24835281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
